# Does Deep Neuromuscular Blockade Improve Operating Conditions During Total Hip Replacements?

> **NCT03219294** · PHASE4 · COMPLETED · sponsor: **Craig Curry** · enrollment: 116 (actual)

## Conditions studied

- Arthropathy of Hip

## Interventions

- **DRUG:** Vecuronium 0.1 mg/kg
- **DRUG:** Vecuronium 0.2mg/kg

## Key facts

- **NCT ID:** NCT03219294
- **Lead sponsor:** Craig Curry
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2018-04-30
- **Final completion:** 2018-05-01
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2019-09-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03219294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03219294, "Does Deep Neuromuscular Blockade Improve Operating Conditions During Total Hip Replacements?". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03219294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*